Where to now?, page-16

I think with such "interesting" control stats - might be worth considering a pause before selling - just to see what comes up. You can't take the tax loss for a while anyway. Can't get very much worse short term you wouldn't think, as a lot of bad is priced in now. This isn't quite the same as other biotech "fails" as far as I can see. You could pluck a number - maybe 25% chance that things may not be as bad as they look.

DYOR - I bought on the plunge yesterday - so might be just talking my own book